Physician profile
Todd Pollock
NPI 1740385376
$4,350.23
in general payments reported to CMS, 2019-2025
15 companies · $707 in 2025
The $707 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $329 · 2021: $285 · 2022: $744 · 2023: $809 · 2024: $667 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,183.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $652.25 | 2022-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $538.51 | 2019-2022 | |
| Tepha INC | $530.64 | 2019 | |
| Abbvie INC. | $433.63 | 2023-2024 | |
| Mentor Worldwide LLC | $387.20 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $385.07 | 2022-2024 | Phasix Mesh |
| Motiva USA, LLC | $326.38 | 2025 | |
| Acera Surgical, INC. | $257.07 | 2023-2024 | Restrata Wound Matrix |
| Sientra, INC. | $202.02 | 2020-2021 | |
| Revance Therapeutics, INC. | $145.09 | 2025 | Daxxify |
| Stryker Corporation | $142.38 | 2019 | |
| Avanos Medical | $130.37 | 2021 | |
| Medical Device Business Services, INC. | $124.32 | 2025 | Dermabond |
| Advanced Oxygen Therapy INC. | $63.05 | 2025 | Topical Oxygen Chamber For Extremities |
| Ethicon US, LLC | $32.25 | 2025 | Stratafix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.